Upper Tract Urothelial Carcinoma (eBook)
XI, 198 Seiten
Springer New York (Verlag)
978-1-4939-1501-9 (ISBN)
Upper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. It's aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage and patient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy is covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC.
Upper Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology.
Shahrokh F. Shariat, M.D.
Professor and Chairman
Department of Urology and Comprehensive Cancer Center
Medical University of Vienna, Vienna General Hospital
Währinger Gürtel 18-20, A-1090 Vienna, Austria
Evanguelos Xylinas, MD
Department of Urology
Cochin Hospital, Paris Descartes University
27 rue du Faubourg Saint Jacques
Paris, 75014, France
Upper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. It's aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage and patient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy is covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC.Upper Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology.
Shahrokh F. Shariat, M.D. Professor and Chairman Department of Urology and Comprehensive Cancer CenterMedical University of Vienna, Vienna General HospitalWähringer Gürtel 18-20, A-1090 Vienna, AustriaEvanguelos Xylinas, MDDepartment of UrologyCochin Hospital, Paris Descartes University27 rue du Faubourg Saint JacquesParis, 75014, France
1. Epidemiology and risk factors for upper urinary urothelial cancersKathleen G. Dickman, Hans-Martin Fritsche, Arthur P. Grollman, George N. Thalmann and James Catto2. Diagnosis and Evaluation of Upper Tract Urothelial Carcinoma (UTUC)Pierre Colin, Wassim Kassouf, Badrinath R. Konety, Yair Lotan, and Morgan Rouprêt3. Upper Urinary Tract Urothelial Carcinoma PathologySteven Christopher Smith, Premal Patel, Mahul B. Amin, and Kiril Trpkov4. Prognostics factors, molecular markers and predictive tools in upper tract urothelial carcinomaEvanguelos Xylinas, Giacomo Novara, Mesut Remzi, Pierre Karakiewicz and Shahrokh F. Shariat5. Conservative management of low-risk UTUCFatima Z. Husain, Mesut Remzi, Vitaly Margulis, Sima P. Porten, Surena F. Matin6. Surgical Management of High-risk Upper Tract Urothelial CarcinomaGeorgios Gakis, Ashish M. Kamat, Vitaly Margulis, Seth P. Lerner and Arnulf Stenzl7. The Role of Lymphadenectomy in the Management of Urothelial Carcinoma of the Upper Urinary Tract Tsunenori Kondo, Bernard H. Bochner, Siamak Daneshmand and Alexandre R. Zlotta8. ChemotherapyArjun Vasant Balar, Matthew D. Galsky, Arlene O. Siefker-Radtke, Scott T. Tagawa, Matthew I. Milowsky
| Erscheint lt. Verlag | 13.9.2014 |
|---|---|
| Zusatzinfo | XI, 198 p. 36 illus., 33 illus. in color. |
| Verlagsort | New York |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie | |
| Schlagworte | aristocholic acid • bladder cancer • distal ureter • Endoluminal ultrasound • Nephroureterectomy • ureteroscopy |
| ISBN-10 | 1-4939-1501-0 / 1493915010 |
| ISBN-13 | 978-1-4939-1501-9 / 9781493915019 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 7,1 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
